Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer

NCT00818350 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Urinary Bladder Neoplasms

Interventions

DRUG: SUNITINIB

Sponsor

Campania Younger Oncologists Association